Compare OVID & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | BHK |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 593.0M |
| IPO Year | 2017 | N/A |
| Metric | OVID | BHK |
|---|---|---|
| Price | $2.19 | $8.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $6.02 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 470.1K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.98 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $8.03 |
| 52 Week High | $3.11 | $10.00 |
| Indicator | OVID | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 40.08 |
| Support Level | $2.18 | N/A |
| Resistance Level | $2.79 | $9.16 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 11.69 | 59.72 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.